Pharma job search #pharma #products

Posted On May 12 2017 by

#pharma job search # 278BioTech / Pharmaceuticalindustry jobs West Login to view salary Responsibilities: Provide support for finance activities: closing, balance sheet. Responsible to maintain and reconcile general ledger. Review and perform monthly amortization of prepayment on monthly basis prior to month-end close. Assist in preparation of statutory and taxation schedules and. Associate Engineer (MNC / Pharmaceutical / East / 5D / Up $3.5k / GMP / Gxp Doc / ) East (Singapore) Login to view salary Our Clients A fast growing and leading pharmaceutical company of high establishment is undergoing expansion plans in the region to support the. West …


Onyx Pharma rejects Amgen s hostile bid #pharmaceutical #business

Posted On May 12 2017 by

#onyx pharma # Onyx Pharmaceuticals, Inc confirmed that it has received and rejected an unsolicited proposal from Amgen Inc. to acquire all of Onyx’s outstanding shares and share equivalents for $120 per share in cash, subject to due diligence and other conditions. The Board of Directors of Onyx had evaluated the proposal made by Amgen with the assistance of its financial and legal advisors and concluded that the price proposed by Amgen significantly undervalued Onyx and its prospects, and was not in the best interest of Onyx or its shareholders. Onyx communicated this determination to Amgen on Friday, June 28, …


Onyx Pharmaceuticals, Inc #dey #pharma

Posted On May 12 2017 by

#onyx pharma # Welcome to the Onyx Pharmaceuticals, Inc. Shareholder Litigation Website This website has been established to provide general information regarding the Onyx Pharmaceuticals, Inc.(“Onyx”) Shareholder Litigation, pending in the Superior Court of California, County of San Mateo (the “Court”). The capitalized terms used on this website and not defined herein shall have the same meanings ascribed to them in the Order Granting Class Certification dated April 10, 2015. If you were a holder of Onyx common stock who received consideration for their shares in the Acquisition of Onyx by Amgen at the price of $125.00 per share who …


TransTech Pharma and Calithera Biosciences Enter Into Worldwide Licensing Agreement for Hexokinase II Inhibitor Program #list #pharmaceutical #companies

Posted On May 12 2017 by

#transtech pharma # TransTech Pharma and Calithera Biosciences Enter Into Worldwide Licensing Agreement for Hexokinase II Inhibitor Program March 05, 2015 04:03 PM Eastern Standard Time HIGH POINT, N.C.–( BUSINESS WIRE )–TransTech Pharma, LLC today announced a global licensing agreement granting Calithera Biosciences, Inc. exclusive world-wide rights to research, develop and commercialize TransTech’s portfolio of hexokinase II inhibitors. TransTech will receive an upfront payment and will be eligible to receive future development and commercialization milestones as well as royalties on sales of approved products. Hexokinase II is the first enzyme in the pathway that enables cancer cells to convert glucose …


Onyx Pharma Releases Promising Multiple Myeloma Study Results #pharmaceuticals #news

Posted On May 12 2017 by

#onyx pharma # Onyx Pharma Releases ‘Promising’ Multiple Myeloma Study Results Jul 26th 2010 9:00AM Onyx Pharmaceuticals (ONXX ) announced what it called “promising results” from a mid-stage study of its experimental drug carfilzomib in patients with relapsed and refractory multiple myeloma. ONXX shares soared 12% in recent premarket activity. Patients in the trial had been previously treated, but stopped responding to standard treatments. But nearly a quarter (24%) of the patients responded to carfilzomib for a median duration of 7.4 months. While this may not sound like a big advancement, such patients with the blood cancer usually respond to …


Bayer HealthCare Pharmaceuticals Inc #medical #market #research

Posted On May 12 2017 by

#bayer schering pharma # Bayer HealthCare Pharmaceuticals Inc. Latest Drug Information Updates Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent. Adlyxin Adlyxin (lixisenatide) is a once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist indicated. Xiidra Xiidra (lifitegrast) is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the. Epclusa Epclusa (sofosbuvir and velpatasvir) is a nucleotide analog polymerase inhibitor and pan-genotypic NS5A. Byvalson Byvalson (nebivolol and valsartan) is a beta adrenergic blocker and an angiotensin II receptor blocker (ARB). Zinbryta Zinbryta (daclizumab) is an interleukin-2 receptor blocking antibody indicated for the treatment of relapsing. More. Was this …


Sun Pharma bets on new products to boost US skincare items rise #dey #pharma

Posted On May 12 2017 by

#sun pharma products # Jun 23, 2016, 05.48 PM | Source: Reuters Sun Pharma bets on new products to boost US skincare items rise The world’s fifth-largest maker of generic drugs was the first among its Indian peers to enter the roughly USD 5 billion US dermatology space by acquiring a controlling stake in Israel’s Taro Pharmaceutical Industries Ltd in 2010. Like this story, share it with millions of investors on M3 Sun Pharma bets on new products to boost US skincare items rise The world’s fifth-largest maker of generic drugs was the first among its Indian peers to enter …


Recruiting Pharmaceutical Physicians: Only Medics #pharmaceutical #sales #rep

Posted On May 12 2017 by

#jobs in pharmaceuticals # Pharmaceutical Physician Jobs Recruiting Physicians for Pharma Only Medics is a specialist international medical recruitment company that focuses exclusively on the recruitment of pharmaceutical physicians for pharmaceutical companies, biotechnology companies, Clinical Research Organisations (CROs) and Regulatory Authorities. We successfully recruit on both a contingent and retained basis on permanent positions as well as interim medical assignments. Our geographic reach is truly global and although our main focus is the European job market, we also recruit for pharmaceutical physician jobs in the US, Canada, Australia and Asia Pacific. Created in 2005, Only Medics was the first of …


Promius Pharma Launches Sernivo™ (betamethasone Dipropionate) Spray, % #world #pharma

Posted On May 12 2017 by

#promius pharma # Promius Pharma Launches Sernivo™ (betamethasone Dipropionate) Spray, 0.05% Dr. Reddy’s Laboratories announced today that its US subsidiary, Promius Pharma, LLC, U.S. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), launched Sernivo™ (betamethasone dipropionate) Spray, 0.05% in the U.S. Sernivo Spray, a prescription topical steroid approved by the Food and Drug Administration (FDA) in February of 2016, is indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older. “We are proud to bring Sernivo Spray to patients across the U.S.,” said Raghav Chari, Executive Vice President, Proprietary Products Group at Dr. Reddy’s …


Sun Pharma MD Dilip Shanghvi expects own products in 2-3 years #jobs #in #pharmaceutical #industry

Posted On May 12 2017 by

#sun pharma products # Sun Pharma MD Dilip Shanghvi expects own products in 2-3 years BS Reporter | Hyderabad Jul 30, 2015 06:54 PM IST Sun Pharmaceutical Industries Limited managing director Dilip Shanghvi today said he expects to have their own innovative products registered in the next 2-3 years in the US and that moment would also validate his belief that one need not spend $2.5 billion in research to develop a new product. Sun Pharma Advanced Research Company (Sparc), which was created over eight years ago by Sun Pharma by spinning off its research activity, has its 3 innovative …